CU20110215A7 - Piperidinas sustituidas - Google Patents
Piperidinas sustituidasInfo
- Publication number
- CU20110215A7 CU20110215A7 CU20110215A CU20110215A CU20110215A7 CU 20110215 A7 CU20110215 A7 CU 20110215A7 CU 20110215 A CU20110215 A CU 20110215A CU 20110215 A CU20110215 A CU 20110215A CU 20110215 A7 CU20110215 A7 CU 20110215A7
- Authority
- CU
- Cuba
- Prior art keywords
- piperidins
- substituted
- prophylaxis
- diseases
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Abstract
La invención se refiere a nuevas piperidinas sustituidas, a procedimientos para su preparación, al uso de las mismas para tratamiento y/o profilaxis de enfermedades y al uso de las mismas para la producción de medicamentos para tratamiento y/o profilaxis de enfermedades, especialmente de trastornos cardiovasculares y trastornos tumorales.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102009022896A DE102009022896A1 (de) | 2009-05-27 | 2009-05-27 | Substituierte Piperidine |
Publications (1)
Publication Number | Publication Date |
---|---|
CU20110215A7 true CU20110215A7 (es) | 2012-03-15 |
Family
ID=42543057
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CU20110215A CU20110215A7 (es) | 2009-05-27 | 2011-11-25 | Piperidinas sustituidas |
Country Status (28)
Country | Link |
---|---|
US (2) | US20120220563A1 (es) |
EP (1) | EP2435427A1 (es) |
JP (1) | JP5718320B2 (es) |
KR (1) | KR20120044289A (es) |
CN (2) | CN104744452A (es) |
AR (1) | AR076692A1 (es) |
AU (1) | AU2010252345A1 (es) |
BR (1) | BRPI1012055A2 (es) |
CA (1) | CA2763400A1 (es) |
CL (1) | CL2011002965A1 (es) |
CO (1) | CO6470823A2 (es) |
CR (1) | CR20110628A (es) |
CU (1) | CU20110215A7 (es) |
DE (1) | DE102009022896A1 (es) |
DO (1) | DOP2011000364A (es) |
EA (1) | EA201190312A1 (es) |
EC (2) | ECSP11011483A (es) |
GT (1) | GT201100300A (es) |
IL (1) | IL215901A0 (es) |
MA (1) | MA33290B1 (es) |
MX (1) | MX2011012505A (es) |
PE (1) | PE20120934A1 (es) |
SG (1) | SG175753A1 (es) |
TN (1) | TN2011000595A1 (es) |
TW (1) | TW201109326A (es) |
UY (2) | UY32636A (es) |
WO (1) | WO2010136144A1 (es) |
ZA (1) | ZA201108565B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102009014484A1 (de) | 2009-03-23 | 2010-09-30 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Piperidine |
DE102009022896A1 (de) | 2009-05-27 | 2010-12-02 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Piperidine |
DE102009022892A1 (de) * | 2009-05-27 | 2010-12-02 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Piperidine |
DE102009022894A1 (de) * | 2009-05-27 | 2010-12-02 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Piperidine |
MX360706B (es) | 2011-10-07 | 2018-11-14 | Takeda Pharmaceuticals Co | Compuestos de 1-arilcarbonil-4-oxi-piperidina utiles para el tratamiento de enfermedades neurodegenerativas. |
CN109311874B (zh) | 2016-04-20 | 2021-07-30 | 百时美施贵宝公司 | 经取代的二环杂环化合物 |
EA201991095A1 (ru) | 2016-11-03 | 2019-09-30 | Бристол-Маерс Сквибб Компани | Замещенные азотсодержащие соединения |
MX2019014411A (es) | 2017-06-01 | 2020-02-05 | Bristol Myers Squibb Co | Compuestos que contienen nitrogeno sustituido. |
WO2023044364A1 (en) | 2021-09-15 | 2023-03-23 | Enko Chem, Inc. | Protoporphyrinogen oxidase inhibitors |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5767144A (en) * | 1994-08-19 | 1998-06-16 | Abbott Laboratories | Endothelin antagonists |
AU2722297A (en) | 1996-04-03 | 1997-10-22 | Merck & Co., Inc. | Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone |
US6403612B2 (en) * | 2000-01-31 | 2002-06-11 | Merck & Co., Inc. | Thrombin receptor antagonists |
MXPA04003480A (es) | 2001-10-15 | 2004-07-30 | Janssen Pharmaceutica Nv | Derivados de 4-fenil-4-(1h-imidazol-2-il)-piperidina sustituida para la reduccion de la lesion isquemica. |
WO2003074495A1 (en) * | 2002-03-01 | 2003-09-12 | Smithkline Beecham Corporation | Hppars activators |
KR20070024639A (ko) | 2004-06-24 | 2007-03-02 | 인사이트 산 디에고 인코포레이티드 | 아미도 화합물 및 약제로서의 이의 용도 |
CN1993128A (zh) * | 2004-06-24 | 2007-07-04 | 因塞特公司 | N-取代的哌啶及它们作为药物的用途 |
JP2008504279A (ja) | 2004-06-24 | 2008-02-14 | インサイト・コーポレイション | アミド化合物およびその医薬としての使用 |
BRPI0512535A (pt) | 2004-06-24 | 2008-03-25 | Incyte Corp | compostos de piperidinas n-substituìdas, suas composições e métodos de modulações |
US20060122197A1 (en) | 2004-08-10 | 2006-06-08 | Wenqing Yao | Amido compounds and their use as pharmaceuticals |
JP2007008913A (ja) * | 2004-09-17 | 2007-01-18 | Tanabe Seiyaku Co Ltd | ピペリジン化合物およびその製法 |
DE102004045796A1 (de) * | 2004-09-22 | 2006-03-23 | Merck Patent Gmbh | Arzneimittel enthaltend Carbonylverbindungen sowie deren Verwendung |
DE102004061750A1 (de) * | 2004-12-22 | 2006-07-06 | Bayer Healthcare Ag | Heteroaryl-substituierte Pyrazoline |
EP1931652A2 (en) | 2005-09-21 | 2008-06-18 | Incyte Corporation | Amido compounds and their use as pharmaceuticals |
WO2007089683A1 (en) | 2006-01-31 | 2007-08-09 | Incyte Corporation | Amido compounds and their use as pharmaceuticals |
WO2007101270A1 (en) | 2006-03-02 | 2007-09-07 | Incyte Corporation | MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
CA2649677A1 (en) | 2006-05-01 | 2007-11-15 | Incyte Corporation | Tetrasubstituted ureas as modulators of 11-.beta. hydroxyl steroid dehydrogenase type 1 |
CA2706991A1 (en) * | 2007-11-30 | 2009-06-04 | Bayer Schering Pharma Aktiengesellschaft | Heteroaryl-substituted piperidines |
DE102009014484A1 (de) * | 2009-03-23 | 2010-09-30 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Piperidine |
DE102009022896A1 (de) | 2009-05-27 | 2010-12-02 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Piperidine |
DE102009022897A1 (de) * | 2009-05-27 | 2010-12-02 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Piperidine |
DE102009022894A1 (de) * | 2009-05-27 | 2010-12-02 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Piperidine |
-
2009
- 2009-05-27 DE DE102009022896A patent/DE102009022896A1/de not_active Withdrawn
-
2010
- 2010-05-13 UY UY0001032636A patent/UY32636A/es not_active Application Discontinuation
- 2010-05-13 UY UY0001032638A patent/UY32638A/es not_active Application Discontinuation
- 2010-05-19 CN CN201510061018.7A patent/CN104744452A/zh active Pending
- 2010-05-19 PE PE2011002010A patent/PE20120934A1/es not_active Application Discontinuation
- 2010-05-19 KR KR1020117028157A patent/KR20120044289A/ko not_active Application Discontinuation
- 2010-05-19 CA CA2763400A patent/CA2763400A1/en not_active Abandoned
- 2010-05-19 CN CN201080036227.1A patent/CN102596944B/zh not_active Expired - Fee Related
- 2010-05-19 JP JP2012512238A patent/JP5718320B2/ja not_active Expired - Fee Related
- 2010-05-19 MX MX2011012505A patent/MX2011012505A/es active IP Right Grant
- 2010-05-19 US US13/321,966 patent/US20120220563A1/en not_active Abandoned
- 2010-05-19 BR BRPI1012055A patent/BRPI1012055A2/pt not_active IP Right Cessation
- 2010-05-19 EP EP10724697A patent/EP2435427A1/de not_active Withdrawn
- 2010-05-19 SG SG2011076833A patent/SG175753A1/en unknown
- 2010-05-19 EA EA201190312A patent/EA201190312A1/ru unknown
- 2010-05-19 MA MA34375A patent/MA33290B1/fr unknown
- 2010-05-19 AU AU2010252345A patent/AU2010252345A1/en not_active Abandoned
- 2010-05-19 WO PCT/EP2010/003059 patent/WO2010136144A1/de active Application Filing
- 2010-05-20 AR ARP100101749A patent/AR076692A1/es not_active Application Discontinuation
- 2010-05-26 TW TW099116745A patent/TW201109326A/zh unknown
- 2010-05-27 US US12/788,529 patent/US8084469B2/en not_active Expired - Fee Related
-
2011
- 2011-10-25 IL IL215901A patent/IL215901A0/en unknown
- 2011-11-22 ZA ZA2011/08565A patent/ZA201108565B/en unknown
- 2011-11-24 CO CO11161612A patent/CO6470823A2/es not_active Application Discontinuation
- 2011-11-24 CL CL2011002965A patent/CL2011002965A1/es unknown
- 2011-11-24 CR CR20110628A patent/CR20110628A/es unknown
- 2011-11-24 TN TNP2011000595A patent/TN2011000595A1/en unknown
- 2011-11-24 DO DO2011000364A patent/DOP2011000364A/es unknown
- 2011-11-25 EC EC2011011483A patent/ECSP11011483A/es unknown
- 2011-11-25 GT GT201100300A patent/GT201100300A/es unknown
- 2011-11-25 EC EC2011011482A patent/ECSP11011482A/es unknown
- 2011-11-25 CU CU20110215A patent/CU20110215A7/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CU20110215A7 (es) | Piperidinas sustituidas | |
PA8784001A1 (es) | Oxazolidinonas sustituidas y su uso | |
CY1117372T1 (el) | Υποκατεστημενες 5-φθορο-1η-πυραζολοπυριδινες και η χρηση τους | |
DK3045456T3 (da) | Bicyklisk substituerede uraciler og anvendelse heraf | |
ECSP099581A (es) | 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y su uso | |
UY31484A1 (es) | Piperidinas heteroaril-sustituidas | |
TN2011000466A1 (en) | Substituted 2-acetamido -5-aryl-1, 2, 4- triazolones and use thereof | |
WO2013151665A3 (en) | Modified polynucleotides for the production of proteins associated with human disease | |
GT200900095A (es) | Dihidropirazolonas sustituidas para el tratamiento de enfermedades cardiovasculares y hermatologicas. | |
EA201200551A1 (ru) | Фармацевтическая композиция, фармацевтическая дозированная форма, способы их получения и применения для лечения | |
DK2243772T3 (da) | Hidtil ukendte P2X7R-antagonister og deres anvendelse | |
EA201690520A1 (ru) | Способ получения замещенных 5-фтор-1h-пиразолопиридинов | |
ATE523510T1 (de) | Substituierte 4-aryl-1,4-dihydro-1,6- naphthyridine und ihre verwendung | |
CO6470822A2 (es) | Piperidinas susituidas | |
UY35746A (es) | Derivados de fenilalanina sustituidos | |
DE502007006625D1 (de) | 3-cyano-5-thiazaheteroaryl-dihydropyridine und ihrnkungen | |
MX2013002261A (es) | N-fenetiltriazolonacetamidas sustituidas y su uso. | |
CL2008001690A1 (es) | Compuestos derivados de oxazolidinonas; su procedimiento de preparacion; y sus usos para preparar un medicamento. | |
BR112013006307A2 (pt) | fenilacetamidas e fenilpropanamidas substituídas e o seu uso | |
UA113887C2 (xx) | 5-амінотетрагідрохінолін-2-карбонові кислоти і їх застосування | |
DOP2005000174A (es) | Fenilaminotiazoles sustituidos y su uso | |
TN2013000243A1 (en) | Substituted 1-benzylcycloalkylcarboxlic acids and use thereof | |
UA111139C2 (uk) | Тверді фармацевтичні композиції і способи їхнього отримання |